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Introduction
Macroautophagy (hereafter referred to as autophagy) is a cellu-
lar degradation system in which cytoplasmic components, includ-
ing organelles, are sequestered by double membrane structures 
called  autophagosomes  and  the  sequestered  materials  are   
degraded by lysosomal hydrolases for supply of amino acids 
and for cellular homeostasis (Rubinsztein, 2006; Levine and 
Kroemer, 2008; Mizushima et al., 2008; Rabinowitz and White, 
2010). Although autophagy has generally been considered non-
selective, recent studies have shed light on another indispensable 
role for basal autophagy in cellular homeostasis, which is medi-
ated by selective degradation of a specific substrate(s) (Kirkin 
et al., 2009; Kraft et al., 2010; Johansen and Lamark, 2011).
p62 is a ubiquitously expressed cellular protein that is con-
served in metazoa but not in plants and fungi, and recently it has 
been  known  as  one  of  the  selective  substrates  for  autophagy 
(Bjørkøy et al., 2005; Pankiv et al., 2007; Ichimura et al., 2008). 
This protein is localized at the autophagosome formation site 
(Itakura and Mizushima, 2011) and directly interacts with LC3, an 
autophagosome localizing protein (Pankiv et al., 2007; Ichimura 
et al., 2008). Subsequently, the p62 is incorporated into the 
autophagosome and then degraded (Pankiv et al., 2007; Ichimura 
et al., 2008). Therefore, impaired autophagy is accompanied by 
accumulation  of  p62  followed  by  the  formation  of  p62  and 
ubiquitinated protein aggregates because of the nature of both self-
oligomerization and ubiquitin binding of p62 (Komatsu et al., 
2007; Nezis et al., 2008).
S
uppression of autophagy is always accompanied 
by marked accumulation of p62, a selective au-
tophagy substrate. Because p62 interacts with the 
Nrf2-binding site on Keap1, which is a Cullin 3–based 
ubiquitin  ligase  adapter  protein,  autophagy  deficiency 
causes competitive inhibition of the Nrf2–Keap1 interaction, 
resulting in stabilization of Nrf2 followed by transcrip-
tional activation of Nrf2 target genes. Herein, we show 
that liver-specific autophagy-deficient mice harbor ade-
nomas linked to both the formation of p62- and Keap1-
positive cellular aggregates and induction of Nrf2 targets. 
Importantly, similar aggregates were identified in more 
than 25% of human hepatocellular carcinomas (HCC), and 
induction of Nrf2 target genes was recognized in most of 
these tumors. Gene targeting of p62 in an HCC cell line 
markedly abrogates the anchorage-independent growth, 
whereas forced expression of p62, but not a Keap1 inter-
action-defective mutant, resulted in recovery of the growth 
defect. These results indicate the involvement of persistent 
activation of Nrf2 through the accumulation of p62 in 
hepatoma development.
Persistent activation of Nrf2 through p62 in 
hepatocellular carcinoma cells
Yoshihiro Inami,
1,2 Satoshi Waguri,
4 Ayako Sakamoto,
1 Tsuguka Kouno,
1 Kazuto Nakada,
6 Okio Hino,
3  
Sumio Watanabe,
2 Jin Ando,
5 Manabu Iwadate,
5 Masayuki Yamamoto,
7 Myung-Shik Lee,
8 Keiji Tanaka,
1  
and Masaaki Komatsu
1
1Protein Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo 156-8501, Japan
2Department of Gastroenterology and 
3Department of Pathology and Oncology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan
4Department of Anatomy and Histology and 
5Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Hikarigaoka,  
Fukushima 960-1295, Japan
6Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8572, Japan
7Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai 980-8575, Japan
8Department of Medicine, Samsung Medical Center, Kangnam-ku, Seoul 135-710, Korea
©  2011  Inami  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 193 • NUMBER 2 • 2011   276
Figure 1.  Loss of Atg7 eventually triggers hepatocellular adenoma. (A) Chronological changes in gross anatomy of livers of Atg7
f/f;Alb-Cre and Atg7
f/f 
mice. Arrows indicate microtumors. Bars, 1 cm. (B) H&E-stained liver sections of Atg7
f/f and Atg7
f/f;Alb-Cre mice aged from 4 to 12 mo. Dashed line: the 
tumor region in the liver of a representative 12-mo-old Atg7
f/f;Alb-Cre mouse. The inset shows higher magnification view of the boxed region containing a 
mitotic cell (arrowhead). C, central vein; P, portal vein. Bars, 100 µm. (C) Liver function tests of Atg7
f/f (blue bars) and Atg7
f/f;Alb-Cre (red bars) mice aged 
from 4 to 12 mo. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were measured. Data are 
means ± SD of Atg7
f/f (n = 3) and Atg7
f/f;Alb-Cre (n = 4) at 4 mo of age, of Atg7
f/f (n = 3) and Atg7
f/f;Alb-Cre (n = 3) at 9 mo of age, and of Atg7
f/f (n = 5) 277 Role of p62 in tumor development • Inami et al.
measuring leakage liver enzymes (Fig. 1 C). Microtumors 
(diameter less than 1 mm) developed randomly throughout 
the liver of 7-mo-old mutant mice but not in age-matched con-
trol mice (Fig. 1 A). The number and size of the tumors in-
creased with age, and several tumors in livers of 12-mo-old 
mutant mice were >5 mm in diameter (Fig. 1 A and Table S1). 
H&E staining indicated that the tumors in Atg7-deficient livers 
were in most cases well demarcated with little fibrous capsule, 
composed of irregular hepatic plates with tumor cells showing 
large nuclear cytoplasmic ratio and occasional nuclear atypia 
(Fig. 1 B). Thus, they were pathologically diagnosed as hepato-
cellular adenoma.
Autophagy deficiency in hepatocytes is 
accompanied by mitochondria dysfunction 
and genomic instability
Electron microscopy showed that the phenotype of nontumor 
regions of Atg7-deficient liver of 12-mo-old mice was basically 
similar to that previously observed in the 3-mo-old Atg7- 
deficient liver (Komatsu et al., 2005). Specifically, abundance of 
smooth ER, presence of numerous deformed mitochondria and 
peroxisomes, and appearance of concentric membranous struc-
tures and aggregates were noted (Fig. 1 D, a and b). Many per-
oxisomes were as big as the mitochondria and often surrounded 
by rough ER-derived double-membrane structures (Fig. 1 D, b). 
Although the tumor regions showed similar changes, the sec-
tions contained larger proportions of deformed mitochondria and 
scarce concentric membranous structures (Fig. 1 D, c and d).
To determine whether the deformed mitochondria observed 
in Atg7-deficient hepatocytes and tumor cells are functionally 
intact, we examined the activity of cytochrome c oxidase (COX) 
enzyme by histochemistry (Inoue et al., 2000). As shown in 
Fig. 1 E, the activity was markedly reduced by loss of Atg7 for 
4 mo, and the reduction worsened with age. Intriguingly, the 
hepatocellular adenoma derived from Atg7-deficient livers also 
exhibited reduced COX activity (Fig. 1 E). These results indi-
cate reduced mitochondrial activity in Atg7-deficient hepatocytes 
and adenoma cells. We also often recognized cells with nuclei 
positive for phospho-histone H2A.X, representing genomic 
instability, in both the nontumor and tumor regions of Atg7-
deficient livers, whereas such cells were not detected in the con-
trol tissues at all (Fig. 1 F). Taken together, it is concluded that 
autophagy deficiency in mouse livers causes tumorigenesis as-
sociated with chronic inflammation, blockade of mitochondrial 
activity, and genome instability.
Activation of Nrf2 in Atg7-deficient tumors
The next series of experiments served to investigate the chrono-
logic changes in the Nrf2–Keap1 pathway in Atg7-deficient livers. 
The Nrf2–Keap1 system is currently recognized as one 
of the major cellular defense mechanisms against oxidative 
and electrophilic stresses. Under quiescent conditions, the 
transcription factor Nrf2 (nuclear factor erythroid 2–related 
factor  2)  is  constitutively  degraded  through  the  ubiquitin– 
proteasome pathway as its binding partner Keap1 (kelch-like 
ECH-associated protein 1) is an adaptor of the ubiquitin ligase 
complex. Exposure to electrophiles, reactive oxygen species, 
and nitric oxide instigates modification of the cysteine resi-
dues of Keap1, leading to Keap1 inactivation. Hence, Nrf2   
becomes stabilized and translocates to the nucleus to induce 
the transcription of numerous cytoprotective genes through   
its  heterodimerization  with  small  Maf  proteins  (Motohashi   
and Yamamoto, 2004; Hayes and McMahon, 2009; Villeneuve 
et al., 2010).
Recently,  we  and  other  groups  independently  reported 
that p62 interacts with the Nrf2-binding site on Keap1, and thus, 
overproduction of p62 or autophagy deficiency competes with 
the interaction between Nrf2 and Keap1, resulting in stabiliza-
tion of Nrf2 followed by transcriptional activation of Nrf2 target 
genes (Copple et al., 2010; Jain et al., 2010; Komatsu et al., 
2010; Lau et al., 2010; Riley et al., 2010). Induction of Nrf2 
target genes has been recognized in many human cancers (Hayes 
and McMahon, 2009) that also show p62 accumulation (Zatloukal 
et al., 2002). However, it is not clear whether p62-induced Nrf2 
activation is involved in tumorigenesis and/or tumor progres-
sion. In this report, we show that liver-specific Atg7 knockout 
mice develop hepatocellular adenoma accompanied by excess 
accumulation of p62 followed by Nrf2 activation, and that per-
sistent activation of Nrf2 through p62 contributes to develop-
ment in human hepatocellular carcinoma.
Results and discussion
Loss of Atg7 in mouse liver causes 
hepatocellular adenoma
Recently, we found that aged mice with liver-specific Atg7 defi-
ciency develop multiple tumors in the livers similar to systemi-
cally mosaic Atg5-deficient mice (Takamura et al., 2011), but 
the exact mechanism of tumorigenesis is still unclear. Thus, we 
first examined the chronologic changes in the liver-specific Atg7-
deficient mice (Atg7
f/f;Alb-Cre; Komatsu et al., 2007), includ-
ing control littermates (Atg7
f/f). Atg7 is an E1-like enzyme for 
both the Atg12 and Atg8 conjugation systems, and is essential 
for autophagy (Tanida et al., 1999). The mutant mice exhibited 
severe hepatomegaly with hepatocyte hypertrophy, as reported 
previously (Komatsu et al., 2005; Fig. 1, A and B). Loss of Atg7 
in mouse livers was also accompanied by inflammation, as judged 
by both hematoxylin and eosin (H&E) staining (Fig. 1 B) and 
and Atg7
f/f;Alb-Cre (n = 5) at 12 mo of age. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (D) Electron microscopy of nontumor hepatocytes (a and b) and 
tumor cells (c and d) in Atg7
f/f;Alb-Cre mouse liver. The boxed regions in a and c are enlarged and shown as b and d, respectively. The inset in b shows 
the higher magnification view of a peroxisome (boxed region in b). Note numerous peroxisomes (asterisks) and accumulation of deformed mitochondria 
(arrowheads) in the peripheral area. Arrows: concentric membranous structures that were consistently present in Atg7-deficient hepatocytes. Nu, nucleus; 
L, lipid droplet. Bars: (a and c) 5 µm; (b and d) 1 µm. (E) Histochemical detection of COX activity in liver sections of Atg7
f/f and Atg7
f/f;Alb-Cre mice aged 
from 4 to 12 mo. Dashed line: liver tumor region in a representative 12-mo-old Atg7
f/f;Alb-Cre mouse. Bar, 10 µm. (F) Phospho-histone H2A.X-positive cells 
in nontumor and tumor regions of 12-mo-old mice of the indicated genotypes. Arrows, cells positive for Phospho-histone H2A.X. Bar, 100 µm.
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variant product that migrates faster was also accumulated in 
both fractions. The quantity of insoluble p62 increased with age, 
and Keap1 was also fractionated into the insoluble fraction 
Immunoblot analysis showed marked accumulation of p62 in liv-
ers of 4-mo-old Atg7
f/f;Alb-Cre mice, and the presence of both the 
soluble and insoluble fractions of p62 (Fig. 2 A). A p62-splicing 
Figure 2.  Activation of Nrf2 in Atg7-deficient hepatocellular adenoma. (A) Immunoblot analysis. Total, soluble, and insoluble fractions were subjected to 
SDS-PAGE and analyzed by immunoblotting with the indicated antibodies. Note that the decrease in conversion of LC3-I to LC3-II, which signifies defective 
autophagosome formation, was confirmed in both the nontumor and tumor regions of the liver of Atg7-deficient mice (Atg7
f/f;Alb-Cre). Data were obtained 
from three independent experiments. (B) Immunofluorescence analysis. Liver nontumor or tumor sections from 12-mo-old mice of the indicated genotypes 
were immunostained with anti-p62 and anti-Keap1 antibodies. The right columns show the merged images of Keap1 (green) and p62 (red). Each inset   
is a magnified image of the boxed region. Bars, 20 µm. (C) qRT-PCR analysis. Total RNAs were prepared from liver or tumor shown in A. Values 
were normalized to the amount of mRNA in the Atg7
f/f liver of 4-mo-old (left) and 12-mo-old mice (right). Data are means ± SD of three experiments. 
**, P < 0.01; ***, P < 0.001.279 Role of p62 in tumor development • Inami et al.
into p62 aggregate structures. Indeed, double immunofluorescence 
microscopy showed that most of the p62-containing aggregates in 
Atg7-deficient nontumor and tumor cells were also positive for 
Keap1 (Fig. 2 B). We confirmed not only the induction of gene 
expression of Nrf2 targets such as NAD(P)H dehydrogenase 
in  proportion  to  the  amount  of  insoluble  p62  (Fig.  2 A).   
Interestingly, accumulation of p62 was also noted in Atg7-
deficient tumor regions as well as in the nontumor regions, and 
significant amounts of p62 and Keap1 were recovered in the   
insoluble fraction (Fig. 2 A), implying sequestration of Keap1 
Figure 3.  Activation of Nrf2 in human HCC containing p62- and Keap1-positive aggregates. (A) Immunohistochemical images. Paraffin sections of a liver 
cancer tissue array were stained with anti-p62 or anti-Keap1 antibody. 6 out of 26 HCC cases containing the typical inclusions are shown. Case codes 
with pathological grade in parenthesis are indicated at the top. Higher magnification views of the boxed regions are shown in the insets. Bars: (panels) 50 µm; 
(insets) 10 µm. (B) Double immunofluorescence microscopy. Three cases of HCC containing typical inclusions were immunostained with anti-Keap1 and 
anti-p62 antibodies. The merged images of Keap1 (green) and p62 (red) are shown on the right. Pathological grades are indicated on the left. Bars, 10 µm.   
(C) qRT-PCR analyses. Total RNAs were prepared from both nontumor and tumor regions of 15 HCCs. Values were normalized to the amount of mRNA in 
the nontumor region of B6 where p62- and Keap1-positive aggregates were not recognized. Data are means ± SD of three experiments.JCB • VOLUME 193 • NUMBER 2 • 2011   280
Nrf2 activation by p62 contributes to 
tumor growth
To further clarify the pathological significance of Nrf2 activa-
tion in human HCC, we used human HCC cell lines. Among the 
six human HCC cell lines examined, Huh-1 and JHH-5 cell lines 
expressed p62 and Nqo1 mRNAs and proteins at relatively high 
levels compared with an immortalized human embryonic kid-
ney cell line, HEK293 (Fig. 4, A and B). Large amounts of 
nuclear Nrf2 protein were also found in those two cell lines 
(Fig. 4 C). Next, p62 knockout clones were generated from 
these two cell lines. The p62 in both cell lines was successfully 
deleted using a zinc finger nuclease system comprised of a class 
of engineered DNA-binding proteins that facilitate targeted   
editing of the genome by creating double-strand breaks in DNA 
at specified locations (Meng et al., 2008; Santiago et al., 2008). 
Disruption of p62 was confirmed by the absence of both p62 
transcript and the protein in p62-deficient cell lines (JHH-5_p62
/ 
and Huh-1_p62
/; Fig. 4, D and E; and unpublished data).   
Importantly, although p62- and Keap1-positive aggregates were 
frequently detected in the cytoplasm of both JHH-5 and Huh-1 
cell lines, such aggregates were completely dispersed by loss of 
p62 (Fig. 4 F), indicating that like a case in autophagy-deficient 
tissues (Komatsu et al., 2007), p62 is responsible for formation 
of the aggregates.
Next, to mimic the physiological environment allowing 
cells to assemble into the three-dimensional (3D) structures 
similar to what is observed in vivo, the parent and p62
/ cell 
lines were subjected to 3D culture. Because the Huh-1 cell line 
did not grow in 3D culture conditions, we used the JHH-5 cell 
line to examine the effect of loss of p62. Quantitative analysis 
showed significant suppression of Nqo1 and Gstm1 expression 
in JHH-5 cells by loss of p62 under the 3D culture conditions 
(Fig. 4 G). Furthermore, the soft agar colony formation assay 
showed a reduced colony formation in JHH-5_p62
/ than pa-
rental JHH-5 (Fig. 4 H), indicating less anchorage-independent 
growth. As expected, such defect was recovered by forced ex-
pression of wild-type p62 but not p62 T350A mutant defective 
in Keap1 interaction (Komatsu et al., 2010) into JHH-5_p62
/ 
(Fig. 4 H and Fig. S1). Collectively, these results emphasize the 
potential role of Nrf2 activation through Keap1 inactivation (by 
accumulation of p62) in hepatoma development.
quinone 1 (Nqo1) and glutathione S-transferase mu1 (Gstm1; 
Fig. 2 C), but also increased quantity of Nrf2 and Nqo1 proteins 
in Atg7-deficient livers and tumor region (Fig. 2 A). Taken 
together, these results indicate persistent activation of Nrf2 in 
Atg7-deficient tumor regions as well as nontumor regions due to 
accumulation of p62.
Activation of Nrf2 in human  
hepatocellular carcinoma
To investigate whether similar events in Atg7-deficient condi-
tions occur in human liver disorders, including hepatitis, liver 
cirrhosis, and hepatocellular carcinoma (HCC), we conducted 
immunohistochemistry for human liver disease tissue arrays 
using anti-p62 and anti-Keap1 antibodies. As reported previously 
(Zatloukal et al., 2002), immunohistochemical analysis with 
anti-p62 antibody showed abundance of p62 and p62-positive   
aggregates in several cases of human HCC (Fig. 3 A). Aggregates 
positive for Keap1 were also found in the HCC cases that showed 
p62 aggregates (Fig. 3 A). As expected, double immunofluores-
cence microscopy demonstrated extensive colocalization of p62 
and Keap1 in numerous aggregates in HCC regardless of the 
pathological grade (Fig. 3 B). Quantitative analysis showed that 
25.5% (26 of 102 patients) and 21.3% (13 of 61 patients) of HCC 
and adjacent tissue of HCC contained p62- and Keap1-positive 
aggregates, respectively (Table I), albeit the aggregates in the 
adjacent tissue of HCC tended to be smaller in size and num-
ber (Fig. 3 A). There was no significant correlation between 
the presence of p62 and Keap1 double-positive aggregates and 
sex, age of tumor onset, or pathological grade (Table S2). These 
aggregates were also detected in tissues of patients with hep-
atitis, liver cirrhosis, and non-HCC tumors, though at lower   
incidence compared with those in HCC and HCC-adjacent 
tissues (Table I).
Is Nrf2 activated in HCC similar to autophagy-deficient 
tumors? To answer this question, quantitative real-time PCR 
(qRT-PCR) was conducted with mRNAs prepared from non-
tumor and tumor regions of HCC patients. The results showed 
marked induction of Nqo1, an Nrf2 target, in 8 out of 15 HCCs 
positive for p62 and Keap1 aggregates (Fig. 3 C). These results 
imply hyperactivation of Nrf2 associated with p62 accumula-
tion in certain types of human HCC.
Table I.  Presence of Keap1 and p62 double-positive aggregates in human liver diseases.
Pathological diagnosis Total number p62 and Keap1  
double-positive lesions
Percentage
Normal 12 0 0.0
Cellular hypertrophy 2 0 0.0
Hepatitis 13 1 7.7
Cirrhosis 40 3 7.5
Hepatocellular carcinoma 102 26 25.5
Tissue adjacent to hepatocellular carcinoma 61 13 21.3
Non-HCC tumor 14 1 7.1
  Clear cell carcinoma 5 0 –
  Bile duct carcinoma 4 1 –
  Metastasis adenoma 3 0 –
  Sarcoma 1 0 –
  Hemangioma 1 0 –281 Role of p62 in tumor development • Inami et al.
Figure 4.  Deletion of p62 suppressed anchorage-independent growth of human HCC cell line. (A) qRT-PCR analyses of p62 and Nqo1 in HCC cell lines. 
Values were normalized to the amount of mRNA in Hek293 cells. Data shown are representative of three separate experiments. (B) Immunoblot analysis. 
Total lysates from the indicated cell lines were subjected to SDS-PAGE and analyzed by immunoblotting with the indicated antibodies. Asterisk indicates 
a nonspecific band. Data were obtained from three independent experiments. (C) Immunoblot analysis of nuclear Nrf2. Nuclear fractions were prepared 
from the indicated cell lines, subjected to SDS-PAGE, and analyzed by immunoblotting with antibodies against Nrf2 and lamin B (as control). Data were 
obtained from three independent experiments. (D) qRT-PCR analysis. Total RNAs were prepared from JHH-5 and JHH-5_p62
/ cells. Values were normal-
ized to the amount of mRNA in JHH-5 cells. (E) Immunoblot analysis of p62. Total lysates from JHH-5 and JHH-5_p62
/ cells were subjected to SDS-PAGE 
and analyzed by immunoblotting with p62 and actin antibodies. (F) Double immunofluorescence microscopy. The indicated cell lines were immunostained 
with anti-p62 and anti-Keap1 antibodies. Bottom row: merged images of p62 (green) and Keap1 (red). Each inset is a magnified image. Bars, 10 µm. 
(G) qRT-PCR analyses of Nrf2 target genes under three-dimensional (3D) culture conditions. Total RNAs were prepared from JHH5 and JHH-5_p62
/ cells   
under 3D culture condition. Values were normalized to the amount of mRNA in the JHH-5. Data are means ± SD of three experiments. ***, P < 0.001. 
(H)  Soft  agar  colony  formation  assay.  The  JHH-5,  JHH-5_p62
/,  and  wild-type  p62-  or  p62  mutant  (p62  T350A)–introduced  JHH5_p62
/  cells   
were tested for their ability to grow in soft agar. The transformation was determined according to the protocol supplied by the manufacturer. RFU, relative 
fluorescent unit. Data are means ± SD of three experiments. *, P < 0.05; ***, P < 0.001.JCB • VOLUME 193 • NUMBER 2 • 2011   282
Conclusion
Autophagy has become a field of interest for cancer researchers 
since Beclin 1, which is involved in both autophagy and endo-
cytosis (He and Levine, 2010), was reported as a tumor suppres-
sor gene (Liang et al., 1999), and mice heterozygous for this 
protein developed cancers spontaneously (Qu et al., 2003; Yue 
et al., 2003). How does autophagy deficiency in mouse livers 
cause tumorigenesis? Systemically mosaic Atg5-deficient mice 
show accumulation of deformed mitochondria followed by oxi-
dative stress and genome instability in the hepatocytes, culminating 
in hepatocellular adenoma (Takamura et al., 2011). Consistent 
with this mouse model, we found that loss of Atg7 in mouse liv-
ers  was  associated  with  tumorigenesis,  which  was  probably 
triggered by mitochondrial dysfunction followed by genome in-
stability (Fig. 1, D–F). In addition to these alterations, chronic 
inflammation was observed in liver-specific Atg7-deficient mice 
(Fig. 1, B and C). Thus, it is conceivable that the inflammatory 
changes also contribute to the tumorigenesis.
Growing lines of evidence indicate that p62 is a scaffold 
protein for cell survival and death-signaling pathways such as the 
NF-B pathway (Sanz et al., 1999; Moscat et al., 2007; Moscat 
and Diaz-Meco, 2009), Wnt signaling (Gao et al., 2010), and 
apoptosis (Jin et al., 2009). Accordingly, it is plausible that 
excess p62 leads to dysregulated activation of these signaling 
pathways. In agreement with this hypothesis, p62 has been 
identified as a component of inclusion bodies found in various 
human diseases including HCC and malignant glioma (Zatloukal 
et al., 2002). Furthermore, the loss of p62 suppressed Ras-
induced lung adenocarcinoma (Duran et al., 2008). Moreover, 
dysregulation of NF-B signal in autophagy-incompetent cells 
was due, at least in part, to accumulation of p62, which subse-
quently enhanced tumorigenesis (Mathew et al., 2009). Those 
lines of evidence suggest the involvement of aberrant signals 
related to p62 accumulation in tumorigenesis. We also propose 
here that persistent activation of Nrf2 through excess accumula-
tion of p62 also contributes to tumor development, as described 
in the following paragraph.
It has been considered over a long time that marked induc-
tion of detoxification enzymes in tumor cells is driven by con-
stant activation of the normal stress response. Recently, somatic 
mutations in Keap1 and Nrf2 were identified in lung, gall blad-
der,  and  head  and  neck  tumors  (Padmanabhan  et  al.,  2006; 
Singh et al., 2006; Shibata et al., 2008a,b). These mutations lead 
to constitutive activation of Nrf2, followed by induction of Nrf2 
target genes, such as cytoprotective enzymes, antioxidant pro-
teins, and multi-drug efflux pumps, thus conferring resistance of 
tumor cells to oxidative stress and anticancer agents (Shibata et al., 
2008b; Hayes and McMahon, 2009). In this regard, the present 
study showed the presence of p62- and Keap1-positive aggre-
gates and induction of Nrf2 targets in HCC (Fig. 3). We also 
noted that cells in areas adjacent to the tumor contained similar 
aggregates, at an incidence (21.3%) comparable to that of tumor 
region (25.5%). Both rates were more than threefold that of 
hepatitis, liver cirrhosis, and non-HCC tumors (Table I). This im-
plies that accumulation and/or aggregation of p62 and Keap1 
could predispose to hepatocarcinogenesis. Importantly, the marked 
induction of Nqo1 in tumor regions with massive accumulation 
of p62 was not associated with increased p62 mRNA expression 
(Fig. 3 C), suggesting that the excess p62 was likely related to 
the suppression of autophagy. Considering cancers with somatic 
mutation of Nrf2 or Keap1, some types of HCC with excess levels 
of p62 would be resistant to oxidative stress and anticancer agents 
through Nrf2 activation without somatic mutations in Nrf2 or 
Keap1. Actually, loss of p62 in human HCC cell line JHH-5 ex-
hibited less anchorage-independent growth than parental cells, 
and such defect was recovered by forced expression of p62 but 
not the mutant defective in Keap1 interaction (Fig. 4 H). These 
results suggest that continuous activation of Nrf2 through ex-
cess accumulation of p62 directly contributes to tumor develop-
ment. Thus, a better understanding of the cellular fluctuations 
associated with p62 accumulation and/or failure of autophagy 
could provide the basis for the development of new therapies 
for HCC.
Materials and methods
Mice
The Atg7
f/f;Alb-Cre mice described previously by our group (Komatsu   
et al., 2007) were used in this study. Mice were housed in specific pathogen- 
free facilities and the experimental protocol was approved by the Ethics 
Review Committee for Animal Experimentation of the Tokyo Metropolitan 
Institute of Medical Science and Juntendo University.
Cell culture and gene targeting
The media and reagents for cell culture were purchased from Life Technolo-
gies. HCC cell lines were provided by Health Science Research Resources 
Bank (Osaka, Japan). Huh-1 and JHH-5 cells were grown in William’s E 
medium containing 10% fetal bovine serum (FBS), 5 U/ml penicillin, and 
50 µg/ml streptomycin. The 3D structures were prepared using the Algi-
Matrix 3D culture system (Invitrogen). Cells were resuspended, inoculated 
at 10
6 cells/well, and then cultured for 7 d. The culture medium was 
changed every other day. The gene targeting for p62 of Huh-1 and JHH-5 
cells was conducted using the CompoZr Zinc Finger Nuclease (Sigma-Aldrich). 
Wild-type p62 and p62 T350A mutant were subcloned into retrovirus vec-
tor, pMXs-puro (Kitamura et al., 2003). As described recently (Ichimura 
et al., 2008), each p62 and p62 T350A vector was introduced into estab-
lished JHH-5_p62
/ cells.
Immunological analysis
Livers were homogenized in 0.25 M sucrose, 10 mM Hepes, pH 7.4, and 
1 mM DTT. The resultant homogenates were fractionated into 0.5% Triton 
X-100 soluble and insoluble fractions. The samples were separated by the 
NuPage system (Invitrogen) with 12% Bis-Tris gels and MOPS-SDS buffer 
and transferred to a polyvinylidene difluoride membrane (Komatsu et al., 
2010). The antibodies for p62 (GP62, Progen Biotechnik), Keap1 (Protein-
tech Group, Inc.), Nqo1 (Abcam), Nrf2 (H-300; Santa Cruz Biotechnol-
ogy, Inc.), actin (MAB1501R; Millipore), and Lamin B (M-20; Santa Cruz 
Biotechnology, Inc.) were purchased from the indicated suppliers. The rabbit 
polyclonal antibodies against Atg7 (Tanida et al., 1999) and LC3 (Komatsu 
et al., 2005) have been described previously.
Human tissue samples
Glass slides with tissue array of various liver diseases were purchased from 
Shanghai Outdo Biotech Co.; Biochain Institute, Inc.; and Biomax, Inc. Fro-
zen tissues and the corresponding mRNAs were purchased from Shanghai 
Outdo Biotech Co. This part of the study was approved by the institutional 
review board of the Tokyo Metropolitan Institute of Medical Science.
Immunofluorescence microscopy
Cells grown on coverslips were fixed in 4% paraformaldehyde in 0.1 M 
phosphate buffer (PB), pH 7.4, for 15 min, permeabilized with 50 µg/ml 
digitonin in PB for 5 min, blocked with 0.1% (vol/vol) gelatin (#G-9391; 
Sigma-Aldrich) in PB for 30 min, and then incubated with primary anti-
bodies for 1 h. After washing, cells were incubated with Alexa Fluor 488–
conjugated goat anti–guinea pig and Alexa Fluor 647–conjugated goat 
anti–rabbit IgG secondary antibodies (Invitrogen) for 30 min. Cells were 283 Role of p62 in tumor development • Inami et al.
age were performed using the Mann-Whitney test, whereas those among 
immunoreactivity  and  histological  grades  were  performed  using  the 
Kruskal-Wallis test. A P-value less than 0.05 denoted the presence of a 
statistical significance.
Online supplemental material
Fig. S1 shows inactivity of the p62 T350A mutant in a Keap1 interaction. 
Table S1 lists frequency of tumorigenesis in Atg7-deficient livers. Table S2 
lists proportions of p62 and Keap1 double-positive cases in human liver 
diseases.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.201102031/DC1.
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imaged using a laser-scanning microscope (LSM510 META; Carl Zeiss, 
Inc.) with a Plan Apochromat 63x NA 1.4 oil differential interference con-
trast objective lens. Image contrast and brightness were adjusted using 
Photoshop CS4 (Adobe).
Histological examination
Fixation  and  embedding  procedures  for  immunohistochemistry  were 
described previously (Waguri and Komatsu, 2009). In brief, mouse livers 
were quickly excised, cut into small pieces, and then fixed by immersing in 
4% paraformaldehyde/4% sucrose in PB. After rinsing, they were embedded 
in paraffin for H&E and Keap1 and p62 stainings, or in OCT compound for 
the staining of phospho-histone H2A.X. As antigen-retrieval procedures, par-
affin sections were autoclaved for 10 min at 121°C in buffer at pH 9.0 and 
6.0 (Nichirei) for Keap1 and p62 stainings, respectively, whereas cryosec-
tions were treated with pepsin solution (Nichirei) for 10 min at 37°C for the 
staining of phospho-histone H2A.X. Sections were blocked and incubated for 
2–3 d at 4°C with the following primary antibodies: guinea pig polyclonal 
antibody against p62 (Progen), rabbit polyclonal antibody against Keap1 
(Proteintech  Group),  and  rabbit  monoclonal  antibody  against  phospho- 
histone H2A.X (Cell Signaling Technology). They were then incubated for 1 h 
with HRP-conjugated donkey anti–guinea pig IgG (Millipore) or goat anti–
rabbit IgG (Histofine simple stain mouse MAX-PO[R]; Nichirei) followed by 
the diaminobenzidine reaction. Double immunofluorescence for p62 and 
Keap1 was performed using Alexa 549–conjugated goat anti–guinea pig 
IgG (Invitrogen) and Dylight 488–conjugated donkey anti–rabbit IgG (Jack-
son ImmunoResearch Laboratories, Inc.), respectively. Cytochrome c oxidase 
(COX) staining was performed as reported previously (Seligman et al., 1968; 
Inoue et al., 2000). In brief, air-dried cryosections (10 µm thick) were incu-
bated in reaction medium: 5 mg diaminobenzidine tetrahydrochloride (DAB), 
9 ml sodium phosphate buffer (0.05 M, pH 7.4), 1 ml catalase (20 µg/ml), 
10 mg cytochrome c, and 750 mg sucrose. COX activity was visualized as a 
brown DAB reaction product.
Images were acquired with a microscope (BX51; Olympus) equipped 
with a 60x objective lens (PlanApoN, NA 1.42, oil; Olympus) and a cooled 
CCD camera system (DP-71; Olympus), or a laser-scanning confocal micro-
scope (FV1000; Olympus) with a 60x objective lens (UPlanSApo, NA 1.35, 
oil; Olympus). After image acquisition, contrast and brightness were adjusted 
using Photoshop CS4 (Adobe).
Electron microscopy
For conventional electron microscopy, small pieces of the liver were fixed by 
immersing in 2% paraformaldehyde/2% glutaraldehyde in PB, post-fixed 
with 1% OsO4, and embedded in Epon 812 (Waguri and Komatsu, 2009). 
After sectioning and staining with uranyl acetate and lead citrate, they were 
observed under an electron microscope (JEM 1200EX; JEOL).
Quantitative real-time PCR (qRT-PCR)
Using a Transcriptor First Strand cDNA Synthesis kit (Roche), the cDNA 
was synthesized from 1 µg of total RNA. Quantitative PCR was performed 
using LightCycler 480 Probes Master (Roche) in a LightCycler 480 (Roche). 
Signals were normalized to -glucuronidase (GUS) for mouse samples and 
to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for human sam-
ples. The sequences of the primers used for mouse samples were: Nqo1F, 
5-AGCGTTCGGTATTACGATCC-3; Nqo1R, 5-AGTACAATCAGGGCTC-
TTCTCG-3; Gstm1F, 5-CTACCTTGCCCGAAAGCAC-3; Gstm1R, 5-ATG-
TCTGCACGGATCCTCTC-3; GusF, 5-CTCTGGTGGCCTTACCTGA-3; 
and GusR, 5-CTCAGTTGTTGTCACCTTCACC-3. The sequences of the 
primers used for human samples were: Nqo1F, 5-AGCGTTCGGTATTACG-
ATCC-3; Nqo1R, 5-AGTACAATCAGGGCTCTTCTCG-3; Gstm1F, 5-TGC-
CCATGATACTGGGGTA-3; Gstm1R, 5-GCCACTGGCTTCTGTCATAAT-3;   
p62F,  5-CAGAGAAGCCCATGGACAG-3;  p62R,  5-AGCTGCCTTG-
TACCCACATC-3;  GapdhF,  5-CTCTGGTGGCCTTACCTGA-3;  and   
GapdhR, 5-CTCAGTTGTTGTCACCTTCACC-3.
Transformation in soft agar
Anchorage-independent  transformation  assays  were  performed  using  a 
CytoSelect 96-well cell transformation assay kit (Cell Biolabs, Inc.). In brief, 
cells were plated in soft agar in a 96-well plate at 5,000 cells/well and 
cultured for 5 d. The transformation was determined according to the pro-
tocol provided by the manufacturer.
Statistical analysis
Values are mean ± SD, including those displayed in the graphs. Statisti-
cal analysis was performed using the unpaired t test (Welch test). Cor-
relation analyses between p62/Keap1 immunoreactivity and sex and JCB • VOLUME 193 • NUMBER 2 • 2011   284
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